UBS AM’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.15K Buy
+95
New +$4.27K ﹤0.01% 3909

Other funds holding ARKG

UBS AM's ARKG Position: Q3 2026 in Review

UBS AM opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 95 shares worth $5.15K. The stake represents ﹤0.01% of the portfolio and ranks #3909 among its holdings.

294 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • UBS AM held 95 shares of ARK Genomic Revolution ETF worth $5.15K as of Q3 2026.
  • ARK Genomic Revolution ETF was a new UBS AM position in Q3 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3909 holding.
  • 294 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.